07 June 2016
Want the secret to living a longer and healthier life? Scientists have found ways to prolong the healthy lifespans of worms, mice, and even monkeys. Their work has revealed exciting new clues about the biology of aging. But solid evidence still shows that the best way to boost the chance of living a long and active life is to follow the advice you likely heard from your parents: eat well, exercise regularly, get plenty of sleep, and stay away from bad habits.
European VC fund hits $280M, with cancer and stroke firms set to benefit
06 June 2016
European venture outfit LSP (Life Sciences Partners) has raised $280 million toward a new biotech fund--surpassing its $170 million target as VC funding continues its healthy run of form in 2016. This is now its fifth fund, which has already started to invest--with the Amsterdam-based firm taking positions in 9 companies.
Health, environmental tracker could head off asthma attacks without drugs
06 June 2016
Currently, asthma treatment involves avoiding irritants and taking medication to relieve symptoms. Researchers at North Carolina State University have created a wearable system that more concretely monitors potential environmental irritants and could predict and potentially prevent asthma attacks.
Cancer cell therapies could be approved next year: Juno, Kite Pharma
06 June 2016
A new wave of experimental cancer drugs that directly recruit the immune system's powerful T cells could begin reaching patients next year, according to companies presenting new data at the annual meeting of the American Society of Clinical Oncology.
ACS Report: Number of US Cancer Survivors Expected to Exceed 20 Million by 2026
06 June 2016
A new report by the American Cancer Society – in collaboration with the National Cancer Institute – estimates there are more than 15.5 million cancer survivors alive in the US today, and that number will grow to more than 20 million by 2026. This includes everyone who’s ever had cancer, from the time of diagnosis for the rest of their life. The report, “Cancer Treatment & Survivorship Facts & Figures 2016-2017,” and an accompanying journal article in CA: A Cancer Journal for Clinicians were released June 2, 2016.
04 June 2016
Detecting AR-V7 positive tumor cells circulating in the blood of an advanced prostate cancer patient predicts that he will not only fail the commonly-prescribed androgen receptor signaling inhibitors (ARSI), abiraterone and enzalutamide, but that he will survive significantly longer if treated with a taxane based chemotherapy regimen.
Big Pharma leads the charge in TV ad spending increases, analyst report finds
03 June 2016
And the spend goes on. The latest pharma ad news is from Morgan Stanley, which notes pharma companies are leading the way in a national TV spending upswing.
Competition watchdog details vaccine market concerns
03 June 2016
Where some see a small cadre of top-notch vaccine companies, others might see an oligopoly. Where some see innovation, others see hard-to-copy jabs that keep generics away and prices high.
02 June 2016
Atlas Genetics Ltd (“Atlas Genetics” or the “Company”), the STI Point-Of-Care (POC) molecular diagnostics company, today notes the major issue of antibiotic resistance for Sexually Transmitted Infections (STIs), as highlighted in the UK Government commissioned anti-microbial resistance report, chaired by Jim O’Neill – ‘Tackling Drug-Resistant Infections Globally’ and recently referenced on the BBC program Newsnight. The O’Neill report recommends that in high income countries health system leaders should ‘support the uptake and use of rapid point-of care diagnostics in primary and secondary care.
How can patients get their money's worth from cancer meds?
02 June 2016
The American Society of Clinical Oncology stepped up the drug-cost debate last year when it proposed a tool to help doctors and patients compare potential treatments. Now, after collecting critiques from providers, patients and the pharma industry, the influential organization has rolled out a new version of that “value framework.”
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Big Pharma’s ROI for drug R&D saw 'welcome' rebound in 2023: report
25 April 2024
Orphan drug market to reach $270B by 2028 : Evaluate
25 April 2024
Russian drug for the treatment of viral hepatitis will be exempt from duty in Mongolia
24 April 2024
PM Mishustin: “We need to increase the production of vital and essential drugs in Russia”
24 April 2024